Skip to main content

Durect Corp

DRRXDelisted Sep 11, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001082038

Durect Corp was delisted on Sep 11, 2025; its insiders filed their last Form 4 on Sep 16, 2025; 40 institutions reported holding it in 13F filings for Q2 2025, worth $4.44M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Durect Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of DRRX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders73156−16
SharesConverted for a 1-for-10 split9.49M27.6K9.30M−166.2K (−1.8%)
Value$54.5M$159.4K$35.1M−$19.2M (−35.4%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Durect Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to DRRX in Q4 2022
InstitutionSharesValue% of portfolio
Jefferies Financial Group Inc.27,565$95.4K0.00%
Bank of Nova Scotia24,039$83.2K0.00%
Susquehanna International Group, LLP11,954$41.4K0.00%
Merit Financial Group, LLC10,088$34.9K0.00%
Group One Trading, L.P.1,394$4.82K0.00%
Harbour Investments, Inc.500$1.73K0.00%
Belpointe Asset Management LLC165$5710.00%
Global Wealth Strategies & Associates20$690.00%
Sofos Investments, Inc.3––

Sold out (25)

Institutions that held Durect Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (1)

Institutions that held Durect Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DRRX in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Jefferies Group LLC275,653$159.4K